Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XKR | ISIN: SE0007331608 | Ticker-Symbol: 6TF
München
22.01.25
08:03 Uhr
33,600 Euro
-2,100
-5,88 %
1-Jahres-Chart
TF BANK AB Chart 1 Jahr
5-Tage-Chart
TF BANK AB 5-Tage-Chart
RealtimeGeldBriefZeit
33,20033,70008:43
GlobeNewswire (Europe)
140 Leser
Artikel bewerten:
(0)

TF Bank AB: Interim Report January - September 2024

Finanznachrichten News

"TF Bank's loan portfolio increased by 20 % in local currencies over the past year and surpassed SEK 20 billion in the third quarter. It is primarily the German credit card business that continues to drive organic growth. The Group's operating profit increased by 47 % compared to the corresponding quarter in 2023." - Joakim Jansson, CEO

January - September 2024 compared to January - September 2023

  • The loan portfolio amounted to SEK 20,279 million, compared to September 2023 the increase in local currencies was 20 %
  • Operating profit increased by 34 % to SEK 496.9 million, including a provision for restructuring costs of SEK 15.9 million in the comparative figure
  • Earnings per share increased by 32 % to SEK 17.00
  • Cost/income ratio improved to 38.7 % (42.1)
  • Return on equity amounted to 23.3 % (22.0)
  • Total capital ratio has decreased to 15.7 % (15.9) since year-end

July - September 2024 compared to July - September 2023

  • The loan portfolio amounted to SEK 20,279 million, compared to September 2023 the increase in local currencies was 20 %
  • Operating profit increased by 47 % to SEK 191.3 million, including a provision for restructuring costs of SEK 15.9 million in the comparative figure
  • Earnings per share increased by 44 % to SEK 6.53
  • Cost/income ratio improved to 36.7 % (42.8)
  • Return on equity amounted to 25.5 % (22.2)

Significant events, January - September 2024

  • The credit card business had an organic loan book growth of 58 % over the past year and economies of scale in the business model have contributed to a significantly improved operating profit of 82% compared to the previous year.
  • Lending operations in Spain and Italy have been established in the Credit Cards segment with a similar offering as in other credit card markets.
  • During September, TF Bank issued Tier 2 bonds in the amount of SEK 100 million and carried out an early redemption of Tier 2 bonds of SEK 100 million.

Significant events after the end of the reporting period

  • The Bank has entered into a share purchase agreement regarding the transfer of a majority stake in the subsidiary Rediem Capital AB

To follow the conference call online, please click on the link below. To ask questions dial in using the number indicated below approximately 15 minutes before the start of the conference and enter the meeting code:

Link: https://www.finwire.tv/webcast/tf-bank/q3-2024/

SE: +46 (0) 850 500 829 end enter the meeting code 812 5551 2583

For further information, please contact:
Mikael Meomuttel, CFO and Head of Investor Relations +46 (0)70 626 95 33

TF Bank in brief
TF Bank was founded 1987 and is a digital bank offering consumer banking services and e-commerce solutions through a proprietary IT platform with a high degree of automation. Lending and/or deposit activities are conducted in Sweden, Finland, Norway, Denmark, Estonia, Latvia, Lithuania, Poland, Germany, Austria, Spain, Ireland, the Netherlands and Italy through subsidiary, branch or cross-border banking with the support of the Swedish banking license. The operations are divided into three segments: Credit Cards, Ecommerce Solutions and Consumer Lending. TF Bank is listed on Nasdaq Stockholm.

This is information which TF Bank is required to disclose under the EU Market Abuse Regulation. The information was provided for publication, through the agency of the contact person set out above, on 15 October 2024 at 07:00 CET.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.